These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 21725609)
21. Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling. Matter WF; Estridge T; Zhang C; Belagaje R; Stancato L; Dixon J; Johnson B; Bloem L; Pickard T; Donaghue M; Acton S; Jeyaseelan R; Kadambi V; Vlahos CJ Biochem Biophys Res Commun; 2001 May; 283(5):1061-8. PubMed ID: 11355880 [TBL] [Abstract][Full Text] [Related]
22. [Inhibitory effects of transfection of arresten gene on liver metastasis from colorectal cancer in nude mice]. Long MY; Li HH; Xu JY; Lai DM; Weng ZH Ai Zheng; 2008 Oct; 27(10):1039-43. PubMed ID: 18851782 [TBL] [Abstract][Full Text] [Related]
23. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase. Igawa T; Lin FF; Rao P; Lin MF Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404 [TBL] [Abstract][Full Text] [Related]
24. PRL-3 activates NF-κB signaling pathway by interacting with RAP1. Lian S; Meng L; Liu C; Xing X; Song Q; Dong B; Han Y; Yang Y; Peng L; Qu L; Shou C Biochem Biophys Res Commun; 2013 Jan; 430(1):196-201. PubMed ID: 23178297 [TBL] [Abstract][Full Text] [Related]
25. PRL-3: a metastasis-associated phosphatase in search of a function. Bessette DC; Wong PC; Pallen CJ Cells Tissues Organs; 2007; 185(1-3):232-6. PubMed ID: 17587829 [TBL] [Abstract][Full Text] [Related]
26. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis. Wang J; Yang Y; Xia HH; Gu Q; Lin MC; Jiang B; Peng Y; Li G; An X; Zhang Y; Zhuang Z; Zhang Z; Kung HF; Wong BC Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428 [TBL] [Abstract][Full Text] [Related]
27. [Intermediate-conductance-Ca2+-activated K+ channels are overexpressed in endometrial cancer and involved in regulating proliferation of endometrial cancer cells]. Wang ZH; Feng YJ; Su M; Yi XF Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):111-5. PubMed ID: 17442186 [TBL] [Abstract][Full Text] [Related]
28. PRL-3 Promotes Ubiquitination and Degradation of AURKA and Colorectal Cancer Progression via Dephosphorylation of FZR1. Zhang C; Qu L; Lian S; Meng L; Min L; Liu J; Song Q; Shen L; Shou C Cancer Res; 2019 Mar; 79(5):928-940. PubMed ID: 30498084 [TBL] [Abstract][Full Text] [Related]
29. Altered expression of phosphatase of regenerating liver gene family in non-small cell lung cancer. Hwang JJ; Min SH; Sin KH; Heo YS; Kim KD; Yoo OJ; Lee SH Oncol Rep; 2012 Feb; 27(2):535-40. PubMed ID: 21993571 [TBL] [Abstract][Full Text] [Related]
30. NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression. Yamaura M; Mitsushita J; Furuta S; Kiniwa Y; Ashida A; Goto Y; Shang WH; Kubodera M; Kato M; Takata M; Saida T; Kamata T Cancer Res; 2009 Mar; 69(6):2647-54. PubMed ID: 19276355 [TBL] [Abstract][Full Text] [Related]
31. The phosphatase of regenerating liver 3 (PRL-3) promotes cell migration through Arf-activity-dependent stimulation of integrin α5 recycling. Krndija D; Münzberg C; Maass U; Hafner M; Adler G; Kestler HA; Seufferlein T; Oswald F; von Wichert G J Cell Sci; 2012 Aug; 125(Pt 16):3883-92. PubMed ID: 22595524 [TBL] [Abstract][Full Text] [Related]
32. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer. Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969 [TBL] [Abstract][Full Text] [Related]
33. Critical role of TRPC6 channels in G2 phase transition and the development of human oesophageal cancer. Shi Y; Ding X; He ZH; Zhou KC; Wang Q; Wang YZ Gut; 2009 Nov; 58(11):1443-50. PubMed ID: 19651628 [TBL] [Abstract][Full Text] [Related]
34. Intermediate-conductance Ca2+-activated K+ channel, KCa3.1, as a novel therapeutic target for benign prostatic hyperplasia. Ohya S; Niwa S; Kojima Y; Sasaki S; Sakuragi M; Kohri K; Imaizumi Y J Pharmacol Exp Ther; 2011 Aug; 338(2):528-36. PubMed ID: 21602424 [TBL] [Abstract][Full Text] [Related]
35. Rhodanine-based PRL-3 inhibitors blocked the migration and invasion of metastatic cancer cells. Min G; Lee SK; Kim HN; Han YM; Lee RH; Jeong DG; Han DC; Kwon BM Bioorg Med Chem Lett; 2013 Jul; 23(13):3769-74. PubMed ID: 23726031 [TBL] [Abstract][Full Text] [Related]
36. Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3. Peng L; Jin G; Wang L; Guo J; Meng L; Shou C Biochem Biophys Res Commun; 2006 Mar; 342(1):179-83. PubMed ID: 16472776 [TBL] [Abstract][Full Text] [Related]
37. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584. Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364 [TBL] [Abstract][Full Text] [Related]
38. Evidence of Decreased Activity in Intermediate-Conductance Calcium-Activated Potassium Channels During Retinoic Acid-Induced Differentiation in Motor Neuron-Like NSC-34 Cells. Chen PC; Ruan JS; Wu SN Cell Physiol Biochem; 2018; 48(6):2374-2388. PubMed ID: 30114691 [TBL] [Abstract][Full Text] [Related]
39. Influenza A virus (H1N1) increases airway epithelial cell secretion by up-regulation of potassium channel KCNN4. Waugh T; Ching JC; Zhou Y; Loewen ME Biochem Biophys Res Commun; 2013 Sep; 438(4):581-7. PubMed ID: 23954634 [TBL] [Abstract][Full Text] [Related]
40. [Phosphatase of regenerating liver-3 (PRL-3) and tumor metastasis]. Peng LR; Shou CC Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):1-3. PubMed ID: 17575683 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]